Full text
PDFPage 697

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BRODY M. J., DIXON R. L. VASCULAR REACTIVITY IN EXPERIMENTAL DIABETES MELLITUS. Circ Res. 1964 Jun;14:494–501. doi: 10.1161/01.res.14.6.494. [DOI] [PubMed] [Google Scholar]
- Berger M., Cüppers H. J., Hegner H., Jörgens V., Berchtold P. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care. 1982 Mar-Apr;5(2):77–91. doi: 10.2337/diacare.5.2.77. [DOI] [PubMed] [Google Scholar]
- Christlieb A. R. Renin, angiotensin, and norepinephrine in alloxan diabetes. Diabetes. 1974 Dec;23(12):962–970. doi: 10.2337/diab.23.12.962. [DOI] [PubMed] [Google Scholar]
- Deckert T., Hansen B., Lauritzen T., Christiansen J. S. Subcutaneous degradation of insulin. Diabetologia. 1981 Aug;21(2):161–162. doi: 10.1007/BF00251287. [DOI] [PubMed] [Google Scholar]
- Ewald U., Tuvemo T., Rooth G. Early reduction of vascular reactivity in diabetic children detected by transcutaneous oxygen electrode. Lancet. 1981 Jun 13;1(8233):1287–1288. doi: 10.1016/s0140-6736(81)92460-0. [DOI] [PubMed] [Google Scholar]
- Greeson T. P., Freedman R. I., Levan N. E., Wong W. H. Cutaneous vascular responses in diabetics. Microvasc Res. 1975 Jul;10(1):8–16. doi: 10.1016/0026-2862(75)90015-1. [DOI] [PubMed] [Google Scholar]
- Hanna A. K., Minuk H. L., Albisser A. M., Marliss E. B., Leibel B. S., Zinman B. A portable system for continuous intravenous insulin delivery: characteristics and results in diabetic patients. Diabetes Care. 1980 Jan-Feb;3(1):1–8. doi: 10.2337/diacare.3.1.1. [DOI] [PubMed] [Google Scholar]
- Klemp P., Staberg B., Madsbad S., Kølendorf K. Smoking reduces insulin absorption from subcutaneous tissue. Br Med J (Clin Res Ed) 1982 Jan 23;284(6311):237–237. doi: 10.1136/bmj.284.6311.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kølendorf K., Bojsen J., Nielsen S. L. Adipose tissue blood flow and insulin disappearance from subcutaneous tissue. Clin Pharmacol Ther. 1979 May;25(5 Pt 1):598–604. doi: 10.1002/cpt1979255part1598. [DOI] [PubMed] [Google Scholar]
- Lauritzen T., Binder C., Faber O. K. Importance of insulin absorption, subcutaneous blood flow, and residual beta-cell function in insulin therapy. Acta Paediatr Scand Suppl. 1980;283:81–85. doi: 10.1111/j.1651-2227.1980.tb15323.x. [DOI] [PubMed] [Google Scholar]
- Maberly G. F., Wait G. A., Kilpatrick J. A., Loten E. G., Gain K. R., Stewart R. D., Eastman C. J. Evidence for insulin degradation by muscle and fat tissue in an insulin resistant diabetic patient. Diabetologia. 1982 Oct;23(4):333–336. doi: 10.1007/BF00253740. [DOI] [PubMed] [Google Scholar]
- Paulsen E. P., Courtney J. W., 3rd, Duckworth W. C. Insulin resistance caused by massive degradation of subcutaneous insulin. Diabetes. 1979 Jul;28(7):640–645. doi: 10.2337/diab.28.7.640. [DOI] [PubMed] [Google Scholar]
- Railton R., Newman P., Hislop J., Harrower A. D. Reduced transcutaneous oxygen tension and impaired vascular response in Type 1 (insulin-dependent) diabetes. Diabetologia. 1983 Oct;25(4):340–342. doi: 10.1007/BF00253198. [DOI] [PubMed] [Google Scholar]
- Williams G., Pickup J. C., Bowcock S., Cooke E., Keen H. Subcutaneous aprotinin causes local hyperaemia. A possible mechanism by which aprotinin improves control in some diabetic patients. Diabetologia. 1983 Feb;24(2):91–94. doi: 10.1007/BF00297388. [DOI] [PubMed] [Google Scholar]
- Williams G., Pickup J., Clark A., Bowcock S., Cooke E., Keen H. Changes in blood flow close to subcutaneous insulin injection sites in stable and brittle diabetics. Diabetes. 1983 May;32(5):466–473. doi: 10.2337/diab.32.5.466. [DOI] [PubMed] [Google Scholar]
